Epicardial adipose tissue and cardiac lipotoxicity: A review

dc.contributor.authorMukherjee, Anirban Goutam
dc.contributor.authorRenu, Kaviyarasi
dc.contributor.authorGopalakrishnan, Abilash Valsala
dc.contributor.authorJayaraj, Rama
dc.contributor.authorDey, Abhijit
dc.contributor.authorVellingiri, Balachandar
dc.contributor.authorGanesan, Raja
dc.date.accessioned2024-01-21T10:44:49Z
dc.date.accessioned2024-08-13T13:21:50Z
dc.date.available2024-01-21T10:44:49Z
dc.date.available2024-08-13T13:21:50Z
dc.date.issued2023-07-05T00:00:00
dc.description.abstractEpicardial adipose tissue (EAT) has morphological and physiological contiguity with the myocardium and coronary arteries, making it a visceral fat deposit with some unique properties. Under normal circumstances, EAT exhibits biochemical, mechanical, and thermogenic cardioprotective characteristics. Under clinical processes, epicardial fat can directly impact the heart and coronary arteries by secreting proinflammatory cytokines via vasocrine or paracrine mechanisms. It is still not apparent what factors affect this equilibrium. Returning epicardial fat to its physiological purpose may be possible by enhanced local vascularization, weight loss, and focused pharmacological therapies. This review centers on EAT's developing physiological and pathophysiological dimensions and its various and pioneering clinical utilities. � 2023 Elsevier Inc.en_US
dc.identifier.doi10.1016/j.lfs.2023.121913
dc.identifier.issn243205
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/3868
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0024320523005489
dc.language.isoen_USen_US
dc.publisherElsevier Inc.en_US
dc.subjectCardiovascular diseaseen_US
dc.subjectEpicardial adipose tissueen_US
dc.subjectFree fatty acidsen_US
dc.subjectLipotoxicityen_US
dc.subjectPPAR-?en_US
dc.titleEpicardial adipose tissue and cardiac lipotoxicity: A reviewen_US
dc.title.journalLife Sciencesen_US
dc.typeReviewen_US
dc.type.accesstypeOpen Accessen_US

Files